Newsroom

Sorted by: Latest

-

Deadline Soon: Replimune Group, Inc. (REPL) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) securities between October 20, 2025 and April 10, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON REPLIMUNE GROUP, INC. INVESTMENTS, CLICK HERE TO PARTICIPA...
-

Deadline Approaching: Replimune Group, Inc. (REPL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith  

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming October 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) securities between October 20, 2025 and April 10, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN REPLIMUNE GROUP, INC. (REPL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE...
-

Deadline Alert: Replimune Group, Inc. (REPL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) securities between October 20, 2025 and April 10, 2026 inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR REPLIMUNE GROUP, INC. INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENT...
-

Riassunto: Energy Vault annuncia un accordo strategico per la distribuzione di un'infrastruttura energetica integrata da 1.25 GW per il data center AI di un hyperscaler, con un'azienda leader nel settore EPC per la generazione di energia...

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--  Energy Vault annuncia un accordo strategico per la distribuzione di un'infrastruttura energetica integrata da 1.25 GW per il data center AI di un hyperscaler, con un'azienda leader nel settore EPC per la generazione di energia che utilizzerà gruppi elettrogeni Caterpillar Energy Vault Holdings, Inc. (NYSE: NRGV) ("Energy Vault"), leader globale nelle infrastrutture energetiche, oggi ha annunciato l'esecuzione di un accordo strategico commerciale graz...
-

ADMA Biologics Deadline: Rosen Law Firm Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased ADMA Biologics securities during the Class Period you may be entitled to compensation without payment of any out of poc...
-

Tikehau Capital : Déclaration des transactions sur actions propres réalisées du 31 juillet 2026 au 06 août 2026

PARIS--(BUSINESS WIRE)--Regulatory News: Tikehau Capital (Paris:TKO) : Conformément à l’article 5 du Règlement européen n° 596/2014 (Règlement MAR – Market Abuse Regulation), les informations détaillées sont disponibles sur le site de Tikehau Capital : https://www.tikehaucapital.com/fr/shareholders/regulatory-information Déclaration des transactions sur actions propres réalisées du 31 juillet 2026 au 06 août 2026   Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transacti...
-

Tikehau Capital: Disclosure of Shares Repurchases From 31 July 2026 to 06 August 2026

PARIS--(BUSINESS WIRE)--Regulatory News:  Tikehau Capital (Paris:TKO): In accordance with Article 5 of EU Regulation n° 596/2014 (Market Abuse Regulation), detailed information is available on the website of Tikehau Capital: https://www.tikehaucapital.com/fr/shareholders/regulatory-information Disclosure of shares repurchases from 31 July 2026 to 06 August 2026   Name of the issuer Issuer Identity Code (LEI) Trading Day ISIN Aggregated volume per day (number of shares) Weighted average price pe...
-

Hilgers Strengthens National Leadership with Three New Partners

LINCOLN, Neb.--(BUSINESS WIRE)--Continuing the firm’s strategic investment in talent and national growth, Hilgers PLLC has promoted Kelsey Shofner, Scott Scheinberg and Will Burgess to partner. The promotions strengthen the firm's leadership in its corporate, litigation and discovery practices and reflect Hilgers' continued expansion in key markets across the country. "As Hilgers continues to grow, we're intentional about investing in leaders who have earned the trust of our clients and colleag...
-

Villa Marconi Engaged in Union Busting as Agency Staff Are Hired to Fill Union Positions

OTTAWA, Ontario--(BUSINESS WIRE)--The union representing staff at Ottawa’s Villa Marconi are calling out their employer’s union busting tactics after discovering agency staff filling in for laid off union members. Members in the laundry department were unceremoniously laid off by management in June, leaving the department short-staffed and under resourced. “We are seeing the same mistakes all over again,” said Andrea Werlen, Recording Secretary for CUPE 4739. “Our employer has been refusing to...
-

ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings

VIENNA--(BUSINESS WIRE)--An ICC Arbitral Tribunal has awarded AOP Orphan Pharmaceuticals GmbH (“AOP Health”) a total of about EUR 112 Mio in a quantum award issued in the ongoing arbitration proceedings with PharmaEssentia Corp. (“PharmaEssentia”) concerning BESREMi® (ropeginterferon alfa-2b). The award quantifies AOP Health’s damage claims for PharmaEssentia’s intentional breaches at ca. EUR 82 Mio. It also awards AOP Health ca. EUR 31 Mio plus interest as reimbursement for AOP Health overpaym...